Press release
US Diabetes Market 2017 - Merck, Astra Zeneca, Novo Nordisk, Johnson and Johnson
The US diabetes market has witnessed a rapid growth in recent years. A significant growth in the number of diabetic patients is the major factor which has contributed in influencing the demand for diabetes management products.Request a free sample copy of the report: http://www.imarcgroup.com/request?type=report&id=688&flag=B
The latest report by IMARC Group titled, “US Diabetes Market Report: 2017 – 2022”, finds that the US diabetes market reached a value of nearly US$ 33 Billion in 2016, growing at a CAGR of more than 13% during 2009-2016. Factors such as high per capita income, ever-growing food processing industry, and sedentary lifestyle have changed the socio-economic structure of the United States dramatically over the past several years. However, these transformations have led to the prevalence of some of the deadly diseases in the region such as diabetes. It is a condition in which the body’s ability to produce or respond to the hormone insulin is impaired, resulting in abnormal metabolism of carbohydrates and elevated levels of glucose in the blood. Diabetes represents the world’s third largest patient pool in 2016. It is largely caused due to rising obesity levels, consumption of processed foods, stress, sedentary lifestyle and genetic factors.
Highlights of the US diabetes market:
A huge number of diabetic patients remains the key driving factor for the growth of the market.
Insulin represents the largest drug type, accounting for the majority of the share.
The market is expected to reach a value of around US$ 67 Billion by 2022.
The United States is a region wherein consumers earn and spend exceedingly, thereby securing plenty of opportunities for the manufacturers in the pharmaceutical industry to create and develop a market for their products. Moreover, more than a half of the population in the US is either obese or overweight. With a large number of diabetic patients, the demand for diabetes management products has increased significantly, such as insulin injection devices and insulin pumps, insulin therapies, oral and injectable diabetes drugs, blood glucose monitoring devices, etc. Additionally, driven by the fact that the US has one of the highest per capita healthcare expenditures, the US market for diabetes is expected to reach a value of US$ 67 Billion by 2022.
Read full report with TOC @ http://www.imarcgroup.com/us-diabetes-market
The market is segmented on the basis of drug type which includes insulin and oral anti-diabetics. Currently, insulin represents the largest market, accounting for the majority of the share. It is highly popular way of administering as it avoids over or under dosing of the drug. An analysis of the competitive landscape provides the details of the key players operative in the market. Some of the major players in the US diabetes market are Merck, Astra Zeneca, Novo Nordisk, and Johnson and Johnson.
Browse related reports:
UK Diabetes Market Report: http://www.imarcgroup.com/UK-diabetes-market
Spain Diabetes Market Report: http://www.imarcgroup.com/spain-diabetes-market
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.Global Cigarette Lighter Market
Contact us
IMARC Group
309 2nd St, Brooklyn, NY 11215, USA
Website: www.imarcgroup.com
Email: sales@imarcgroup.com
USA: +1-631-791-1145
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US Diabetes Market 2017 - Merck, Astra Zeneca, Novo Nordisk, Johnson and Johnson here
News-ID: 784348 • Views: …
More Releases from IMARC Group

India Seafood Market Outlook 2025-2033: Key Trends, Size, Share and Growth Insig …
As indicated in the latest market research report published by IMARC Group, titled "India Seafood Market Report by Type (Fish, Shrimps, Others), Form (Fresh/Chilled, Frozen/Canned, Processed), Distribution Channel (Off Trade, On Trade), and Region 2025-2033," this report provides an in-depth analysis of the industry, featuring insights into the market. It encompasses competitor and regional analyses, as well as recent advancements in the market.
Market Size & Future Growth Potential:
The India seafood…

India Mutual Funds Market: Size, Share, Trends, Growth and Industry Outlook 2025 …
Mutual Funds Market in India 2025:
Base Year: 2024
Historical Years: 2019-2024
Forecast Years: 2025-2033
Market Size in 2024: USD 2.50 Billion
Market Size in 2033: USD 5.90 Billion
Market Growth Rate (CAGR) 2025-2033: 10.03%
How Big is the India Mutual Funds Industry?
The India mutual funds market size reached USD 2.50 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.90 Billion by 2033, exhibiting a growth rate (CAGR) of 10.03% during 2025-2033.
Request…

Dimethyl Ether Market Valuation to Reach USD 15.73 Billion by 2033 - Industry Ex …
Market Overview:
The dimethyl ether market is experiencing significant growth momentum, driven by increasing demand for cleaner fuel alternatives, expanding applications in various industries, and supportive government policies promoting sustainable energy solutions. According to IMARC Group's latest research publication, "Dimethyl Ether Market Size, Share, Trends and Forecast by Raw Material, Application, End-Use Industry, and Region, 2025-2033", the global dimethyl ether market size reached USD 7.22 Billion in 2024. Looking forward, IMARC…

Glucometer Manufacturing Plant Report 2025: Unit Setup, Cost and Requirements, P …
Setting up a glucometer manufacturing plant requires thorough market research alongside a minute understanding of numerous operating factors such as unit processes, purchasing of raw materials, utility supply, infrastructure creation, equipment and technology specifications, human resource planning, logistics, and cash outlay.
IMARC Group's report titled "Glucometer Manufacturing Plant Cost Analysis Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Emerging trends for Diabetes Care Devices Market 2020 astonishing growth by Worl …
The global diabetes care devices market is expected to reach US$ 39,382.3 Mn in 2027 from US$ 23,354.3 Mn in 2018. The market is estimated to grow with a CAGR of 6.1% from 2020-2027.
Premium market insights recently published a report titled "Diabetes Care Devices Market Size and Forecast to 2026". The report includes an authentic and accurate research study into the global Diabetes Care Devices market based on a qualitative…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…